Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

James M Cook

Showing results (311-320 of 329) with videos related to

Pageof 33
Sort By:
Biopharmaceutics & Drug Disposition|February 23, 2022
Metabolism, pharmacokinetics, and anticonvulsant activity of a deuterated analog of the α2/3-selective GABAkine KRM-II-81Lalit K Golani, Branka Divović, Dishary Sharmin, et al.
The Journal of Pharmacology and Experimental Therapeutics|February 6, 2023
Structural Analogs of the GABAkine KRM-II-81 Are Orally Bioavailable Anticonvulsants without SedationKamal P Pandey, Branka Divović, Farjana Rashid, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|September 12, 2003
The reinforcing properties of alcohol are mediated by GABA(A1) receptors in the ventral pallidumHarry L June, Katrina L Foster, Peter F McKay, et al.
Molecular Pharmaceutics|October 22, 2019
Correction to "A Novel Orally Available Asthma Drug Candidate That Reduces Smooth Muscle Constriction and Inflammation by Targeting GABA<sub>A</sub> Receptors in the Lung"Gloria S Forkuo, Amanda N Nieman, Revathi Kodali, et al.
Journal of Neuro-Oncology|February 7, 2019
Modulating native GABA<sub>A</sub> receptors in medulloblastoma with positive allosteric benzodiazepine-derivatives induces cell deathLaura Kallay, Havva Keskin, Alexandra Ross, et al.
Molecular Pharmaceutics|March 27, 2018
A Novel Orally Available Asthma Drug Candidate That Reduces Smooth Muscle Constriction and Inflammation by Targeting GABA<sub>A</sub> Receptors in the LungGloria S Forkuo, Amanda N Nieman, Revathi Kodali, et al.
ACS Chemical Neuroscience|January 4, 2024
New Imidazodiazepine Analogue, 5-(8-Bromo-6-(pyridin-2-yl)-4<i>H</i>-benzo[<i>f</i>]imidazo[1,5-<i>a</i>][1,4]diazepin-3-yl)oxazole, Provides a Simplified Synthetic Scheme, High Oral Plasma and Brain Exposures, and Produces Antiseizure Efficacy in Mice, and Antiepileptogenic Activity in Neural Networks in Brain Slices from a Patient with Mesial Temporal Lobe EpilepsyDishary Sharmin, Branka Divović, Xingjie Ping, et al.
Molecular Pharmaceutics|April 28, 2016
Development of GABAA Receptor Subtype-Selective Imidazobenzodiazepines as Novel Asthma TreatmentsGloria S Forkuo, Margaret L Guthrie, Nina Y Yuan, et al.
Cancers|September 28, 2024
GABA(A) Receptor Activation Drives GABARAP-Nix Mediated Autophagy to Radiation-Sensitize Primary and Brain-Metastatic Lung Adenocarcinoma TumorsDebanjan Bhattacharya, Riccardo Barrile, Donatien Kamdem Toukam, et al.
Molecular Pharmaceutics|April 26, 2017
Alleviation of Multiple Asthmatic Pathologic Features with Orally Available and Subtype Selective GABA<sub>A</sub> Receptor ModulatorsGloria S Forkuo, Amanda N Nieman, Nina Y Yuan, et al.
Pageof 33

Showing results (311-320 of 329) with videos related to

Sort By:
Pageof 33
Biopharmaceutics & Drug Disposition|February 23, 2022
Metabolism, pharmacokinetics, and anticonvulsant activity of a deuterated analog of the α2/3-selective GABAkine KRM-II-81Lalit K Golani, Branka Divović, Dishary Sharmin, et al.
The Journal of Pharmacology and Experimental Therapeutics|February 6, 2023
Structural Analogs of the GABAkine KRM-II-81 Are Orally Bioavailable Anticonvulsants without SedationKamal P Pandey, Branka Divović, Farjana Rashid, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|September 12, 2003
The reinforcing properties of alcohol are mediated by GABA(A1) receptors in the ventral pallidumHarry L June, Katrina L Foster, Peter F McKay, et al.
Molecular Pharmaceutics|October 22, 2019
Correction to "A Novel Orally Available Asthma Drug Candidate That Reduces Smooth Muscle Constriction and Inflammation by Targeting GABA<sub>A</sub> Receptors in the Lung"Gloria S Forkuo, Amanda N Nieman, Revathi Kodali, et al.
Journal of Neuro-Oncology|February 7, 2019
Modulating native GABA<sub>A</sub> receptors in medulloblastoma with positive allosteric benzodiazepine-derivatives induces cell deathLaura Kallay, Havva Keskin, Alexandra Ross, et al.
Molecular Pharmaceutics|March 27, 2018
A Novel Orally Available Asthma Drug Candidate That Reduces Smooth Muscle Constriction and Inflammation by Targeting GABA<sub>A</sub> Receptors in the LungGloria S Forkuo, Amanda N Nieman, Revathi Kodali, et al.
ACS Chemical Neuroscience|January 4, 2024
New Imidazodiazepine Analogue, 5-(8-Bromo-6-(pyridin-2-yl)-4<i>H</i>-benzo[<i>f</i>]imidazo[1,5-<i>a</i>][1,4]diazepin-3-yl)oxazole, Provides a Simplified Synthetic Scheme, High Oral Plasma and Brain Exposures, and Produces Antiseizure Efficacy in Mice, and Antiepileptogenic Activity in Neural Networks in Brain Slices from a Patient with Mesial Temporal Lobe EpilepsyDishary Sharmin, Branka Divović, Xingjie Ping, et al.
Molecular Pharmaceutics|April 28, 2016
Development of GABAA Receptor Subtype-Selective Imidazobenzodiazepines as Novel Asthma TreatmentsGloria S Forkuo, Margaret L Guthrie, Nina Y Yuan, et al.
Cancers|September 28, 2024
GABA(A) Receptor Activation Drives GABARAP-Nix Mediated Autophagy to Radiation-Sensitize Primary and Brain-Metastatic Lung Adenocarcinoma TumorsDebanjan Bhattacharya, Riccardo Barrile, Donatien Kamdem Toukam, et al.
Molecular Pharmaceutics|April 26, 2017
Alleviation of Multiple Asthmatic Pathologic Features with Orally Available and Subtype Selective GABA<sub>A</sub> Receptor ModulatorsGloria S Forkuo, Amanda N Nieman, Nina Y Yuan, et al.
Pageof 33